Harvard University chemist Daniel Kahne has spent much of his career studying the fundamentals of how bacteria thrive and evade attack.
His lab has a special interest in gram-negative bacteria, which have an outer membrane that many antibiotics cannot cross.
Among these bacteria is carbapenem-resistant Acinetobacter baumannii, or CRAB. Designated by the World Health Organization as a “critical priority” for antibiotic development, CRAB kills hundreds of critically ill patients in the U.S....
Read more about New research: Paving the Way for a New Class of Antibiotics
